Boston Scientific shelled out $533 million to buy up the remaining equity it had in Nalu Medical, a private company that produces a miniaturized neurostimulation implant aimed at treating chronic pain ...
Original Image Link
Source:www.fiercebiotech.com
Original Image Link
Source:www.fiercebiotech.com
Posted: 2025-10-20 09:04:00